Leadership & Advisors

Each sector team meets weekly to discuss coverage, advance thesis development, and review new clinical data. The Investment Committee meets bi-monthly to receive formal pitches from sector teams.

We host a regular speaker series bringing in biopharma investors, biotech founders, FDA advisors, and life sciences professionals to share real-world perspectives on drug development and investing.

Our Investment Committee process is deliberately adversarial. Theses are challenged, assumptions are pressure-tested, and members are expected to defend their views under critical questioning.

Senior members provide direct mentorship to junior analysts — helping them navigate the steep learning curve of biopharma investing and accelerate their development as analysts and future professionals.